Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Urban

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Frontiers in Immunology|May 7, 2024
CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cellsSophia Schreiber, Lisa S Dressler, Eva Loffredo-Verde, et al.
Journal of Medical Virology|May 28, 2024
Development of a single-domain antibody to target a G-quadruplex located on the hepatitis B virus covalently closed circular DNA genomeGerardo B Figueroa, Simmone D'souza, Higor S Pereira, et al.
Hepatology (Baltimore, Md.)|February 3, 2015
Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout miceDavor Slijepcevic, Christina Kaufman, Catharina G K Wichers, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2025
Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis DeltaPietro Lampertico, Pavel O Bogomolov, Vladimir Chulanov, et al.
Journal of Hepatology|May 20, 2018
Erratum to "A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction" [J Hepatol 67 (2017) 669-679]Lester Suárez-Amarán, Carla Usai, Marianna Di Scala, et al.
Journal of Hepatology|April 16, 2019
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacyCihan Yurdaydin, Zaigham Abbas, Maria Buti, et al.
Scientific Reports|May 28, 2016
Restrictive influence of SAMHD1 on Hepatitis B Virus life cycleAndreas F R Sommer, Lise Rivière, Bingqian Qu, et al.
Plos Pathogens|August 8, 2020
Nuclear PYHIN proteins target the host transcription factor Sp1 thereby restricting HIV-1 in human macrophages and CD4+ T cellsMatteo Bosso, Caterina Prelli Bozzo, Dominik Hotter, et al.
Journal of Hepatology|May 22, 2017
A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β inductionLester Suárez-Amarán, Carla Usai, Marianna Di Scala, et al.
Gastroenterology|February 8, 2018
HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of InterferonPascal Mutz, Philippe Metz, Florian A Lempp, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Frontiers in Immunology|May 7, 2024
CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cellsSophia Schreiber, Lisa S Dressler, Eva Loffredo-Verde, et al.
Journal of Medical Virology|May 28, 2024
Development of a single-domain antibody to target a G-quadruplex located on the hepatitis B virus covalently closed circular DNA genomeGerardo B Figueroa, Simmone D'souza, Higor S Pereira, et al.
Hepatology (Baltimore, Md.)|February 3, 2015
Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout miceDavor Slijepcevic, Christina Kaufman, Catharina G K Wichers, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 24, 2025
Phase 2 Randomised Study of Bulevirtide as Monotherapy or Combined With Peg-IFNα-2a as Treatment for Chronic Hepatitis DeltaPietro Lampertico, Pavel O Bogomolov, Vladimir Chulanov, et al.
Journal of Hepatology|May 20, 2018
Erratum to "A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction" [J Hepatol 67 (2017) 669-679]Lester Suárez-Amarán, Carla Usai, Marianna Di Scala, et al.
Journal of Hepatology|April 16, 2019
Treating chronic hepatitis delta: The need for surrogate markers of treatment efficacyCihan Yurdaydin, Zaigham Abbas, Maria Buti, et al.
Scientific Reports|May 28, 2016
Restrictive influence of SAMHD1 on Hepatitis B Virus life cycleAndreas F R Sommer, Lise Rivière, Bingqian Qu, et al.
Plos Pathogens|August 8, 2020
Nuclear PYHIN proteins target the host transcription factor Sp1 thereby restricting HIV-1 in human macrophages and CD4+ T cellsMatteo Bosso, Caterina Prelli Bozzo, Dominik Hotter, et al.
Journal of Hepatology|May 22, 2017
A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β inductionLester Suárez-Amarán, Carla Usai, Marianna Di Scala, et al.
Gastroenterology|February 8, 2018
HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of InterferonPascal Mutz, Philippe Metz, Florian A Lempp, et al.
Pageof 14